Latest CMS NADAC release

Weekly NADAC Price Changes

A weekly executive brief covering the pricing movements that matter most to market strategy and reimbursement planning.

Week of August 19, 2026

Compared with August 12, 2026

Weekly NADAC pricing brief

Pricing pressure broadened across endocrine and respiratory products as a small set of high-volume therapies drove the week’s largest shifts.

The latest release shows a concentrated pattern of movement rather than a broad market-wide reset. Most of the week’s largest increases were concentrated in a narrow group of high-exposure products, while relief remained more fragmented across lower-cost oral therapies.

Key takeaways

  • Endocrine products posted the largest weighted movement this week.
  • The biggest increases were concentrated in high-exposure therapies rather than across the entire market.
  • Downward movement remained fragmented, suggesting pricing relief is still uneven.

What to watch

Endocrine pressure

Whether the largest increases continue to be driven by a small number of high-exposure NDCs.

Respiratory volatility

Whether volatility broadens beyond the current concentration of price swings.

Manufacturer shifts

Whether supply-side pricing moves begin to spread across more products in the next release.

Largest cost pressure

$12.8MUp

Largest absolute weekly price increase in the current release

Largest relief

$8.4MDown

Largest absolute weekly price decline in the current release

Most pressured class

Highest weighted movement this week

Largest manufacturer swing

Largest aggregate movement across tracked NDCs

Top 10 NDCs by weekly price movement

Up to 10 changed products are shown. Each edition preserves its published price comparison.

Notes and methodology

How the weekly brief calculations were ranked, aggregated, and preserved for archive consistency.

Top mover ranking

The Top 10 table ranks NDCs by absolute weekly impact: the change in unit price multiplied by dispensing exposure when available.

Segment summaries

Drug markets, manufacturers, and therapeutic classes aggregate the same NDC-level deltas. Average move is the mean percent change, while impact is the summed dollar-weighted effect using absolute price impact because dispensing-volume weighting was unavailable.

Headline cards and archive stability

Most pressured class selects the largest positive class impact, and largest manufacturer swing selects the manufacturer with the largest aggregate absolute impact. Every weekly brief stores a frozen snapshot so archived pages do not drift when live NADAC data changes.

Recent editions

Each edition is permanently archived under its release date.

Full archive

Explore the broader trend ecosystem